Tisch Multiple Sclerosis Research Center Of New York Inc

Organization Overview

Tisch Multiple Sclerosis Research Center Of New York Inc is located in New York, NY. The organization was established in 2015. According to its NTEE Classification (H48) the organization is classified as: Brain Disorders Research, under the broad grouping of Medical Research and related organizations. As of 12/2021, Tisch Multiple Sclerosis Research Center Of New York Inc employed 47 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Tisch Multiple Sclerosis Research Center Of New York Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2021, Tisch Multiple Sclerosis Research Center Of New York Inc generated $12.6m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 5.7% each year. All expenses for the organization totaled $9.9m during the year ending 12/2021. While expenses have increased by 4.4% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

THE PURPOSE OF TISCH MULTIPLE SCLEROSIS RESEARCH CENTER OF NY, INC. IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD FINDING THE CAUSE AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS.

Describe the Organization's Program Activity:

Part 3 - Line 4a

TISCH MS RESEARCH CENTER OF NEW YORK'S (TISCH MSRCNY) MISSION IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD DISCOVERING THE CAUSE OF AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS. IN 2021, ADVANCEMENTS WERE MADE IN THE STEM CELL RESEARCH PROGRAM. DRS HARRIS AND SADIQ CONDUCTED A LONG TERM FOLLOW UP STUDY OF MS PATIENTS IN THE PHASE I CLINICAL TRIAL, WHICH WAS PUBLISHED IN THE JOURNAL NEUROLOGY NEUROIMMUNOLOGY AND NEUROINFLAMMATION. THE PHASE II CLINICAL TRIAL OF STEM CELL IN MS WAS FULLY ENROLLED WITH NO SERIOUS ADVERSE EVENTS RELATED TO THE TREATMENT. CLINICAL TRIAL RESULTS ARE EXPECTED IN 2023. IN ADDITION, TISCH MSRCNY RESEARCHERS WERE INVITED TO PRESENT RESEARCH ABSTRACTS AT ANNUAL CONFERENCES OF THE AMERICAN ACADEMY OF NEUROLOGY, THE INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH AND THE SOCIETY FOR NEUROSCIENCE, ALL HELD VIRTUALLY IN 2021. IN 2021, TISCH MSRCNY CONTINUED CONSTRUCTION ON A NEW FACILITY, THE EXPERIMENTAL RESEARCH CENTER, AN EXPANSION OF THE EXISTING LABORATORIES. THIS PROJECT IS EXPECTED TO BE COMPLETED BY FALL OF 2022.


AS AN ACADEMIC FACILITY, THE TISCH MS RESEARCH CENTER PROVIDES EDUCATIONAL AND TRAINING RESOURCES FOR MS RESEARCHERS AND MEDICAL PROFESSIONALS. ONE OF THE MOST IMPORTANT GOALS OF TISCH MSRCNY IS TO PROVIDE RESEARCH OPPORTUNITIES FOR YOUNG SCIENCE GRADUATES THAT ENABLE THEM TO BECOME CAREER SCIENTISTS. SINCE ITS INCEPTION, THEY HAVE TRAINED OVER 100 COLLEGE GRADUATES AS RESEARCH ASSISTANTS (RAS) FOR 2-YEAR ROTATIONS. IN 2021, ALL SECOND YEAR RESEARCH ASSISTANTS, UNDER THE GUIDANCE OF TISCH MSRCNY PRINCIPAL INVESTIGATORS, MATRICULATED TO TOP MEDICAL SCHOOLS AND GRADUATE PROGRAMS. FELLOWSHIPS IN MS RESEARCH ARE ALSO OFFERED TO PHYSICIANS AND SCIENTISTS INTERESTED IN ENTERING OR EXPANDING THEIR WORK IN THIS FIELD. WEEKLY JOURNAL CLUB MEETINGS OR GRAND ROUNDS TAKE PLACE IN OUR CONFERENCE ROOM OR VIRTUALLY TO DISCUSS THE LATEST ADVANCEMENTS IN MS RESEARCH AND HOW IT APPLIES TO OUR CURRENT INVESTIGATIONS. THESE RESEARCH INITIATIVES INCLUDE: TO BETTER UNDERSTAND AND TREAT COORDINATION AND BALANCE DIFFICULTIES IN PATIENTS WITH MS. TO CREATE AN EXPERIMENTAL MODEL OF PROGRESSIVE MS THAT WILL ENABLE US TO BETTER UNDERSTAND AND TREAT PATIENTS WITH SECONDARY PROGRESSIVE MS (SPMS) AND PRIMARY PROGRESSIVE MS (PPMS). TO UTILIZE NOVEL CEREBROSPINAL FLUID BASED ANIMAL MODELS TO BETTER UNDERSTAND OTHER NEURODEGENERATIVE DISEASES SUCH AS ALS TO DEVELOP ORGANOID MODELS TO BETTER UNDERSTAND THE UNDERPINNINGS OF PROGRESSIVE MS FINALLY, AND PERHAPS MOST IMPORTANTLY, WE NEED TO IDENTIFY THE INTITIAL TRIGGER(S) THAT CAUSE MS.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Trademark Mechanical
Hvac Installation
$2,047,493
Denmar Electric Corp
Electrical Installation
$293,210
Conroy Construction
General Contracting
$303,252
Abm Systems Inc
Mechanical Services
$448,750
Stephen Foy Mechanical Service Corp
Mechanical Services
$627,707
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$2,768,420
Related organizations$0
Government grants $574,695
All other contributions, gifts, grants, and similar amounts not included above$9,281,826
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$12,624,941
Total Program Service Revenue$0
Investment income $1,227
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales -$4,875
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $12,621,293

Grants Recieved

Over the last fiscal year, we have identified 26 grants that Tisch Multiple Sclerosis Research Center Of New York Inc has recieved totaling $2,729,505.

Awarding OrganizationAmount
Jewish Communal Fund

New York, NY

PURPOSE: GENERAL SUPPORT

$1,627,536
Moccasin Lake Foundation

wilmington, DE

PURPOSE: GENERAL & UNRESTRICTED

$450,000
Schwab Charitable Fund

San Francisco, CA

PURPOSE: HEALTH

$315,900
Goldman Sachs Philanthropy Fund

New York, NY

PURPOSE: MEDICAL / PUBLIC SERVICES

$105,000
Harry F Mariani Family Foundation

Locust Valley, NY

PURPOSE: GENERAL SUPPORT

$50,000
American Endowment Foundation

Hudson, OH

PURPOSE: MEDICAL RESEARCH

$38,000
View Grant Recipient Profile

Create an account to unlock the data you need.

or